30 April 2021

GSK Stockmann in Luxembourg named “Luxembourg Capital Markets Firm of the Year” at the IFLR Europe Awards 2021

Following the announcement of the winners at the virtual ceremony of the IFLR Europe Awards 2021, GSK Stockmann in Luxembourg has been named “Luxembourg Capital Markets Firm of the Year”.

The International Financial Law Review (IFLR) is a market-leading financial law publication for in-house counsels and law firms specializing in financial law. The annual IFLR Europe Awards recognize the most innovative firms, teams and deals of the year and are based on a combination of submissions and preliminary research undertaken by IFLR.

The full list of winners of the IFLR Europe Awards 2021 is available on the IFLR website.

IFLR Awards Editor James Wilson says: “GSK Stockmann wins the Luxembourg Capital Markets Firm of the Year Award 2021. Some of the firm’s most innovative work came in the equity capital markets, securitisations and on hybrid instruments.”

Andreas Heinzmann, Partner at GSK Stockmann in Luxembourg, comments: “We are honoured to win the IFLR Europe Awards 2021 in the category “Luxembourg Capital Markets Firm of the Year”. The recognition reflects our regional reputation as well as the ongoing growth and development of the Luxembourg office since its inception in 2016.”

“We are delighted to have been recognised for our work in Capital Markets. The award underlines our successful work and positioning in the market. We would like to express our sincere thanks to IFLR, to our clients and business partners for their ongoing trust and positive feedback as well as to our team for their dedication and excellent work”, adds Dr. Philipp Mössner, Partner at GSK Stockmann in Luxembourg.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 07.05.2021

    GSK Update: Introducing the new sustainable finance measures of the EU Commission

    Read more
  • 30.03.2021

    GSK Update: SFDR – new RTS – What you should know

    Read more
  • 10.02.2021

    GSK Update: Blockchain II Law: Another step forward for the digitalization of EU capital markets

    Read more
Contact person

Andreas Heinzmann, LL.M.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Dr. Philipp Mössner, LL.M.

Partner

+352 271802-40

philipp.moessner@gsk-lux.com

© GSK Stockmann 2021